W Truong, JC Plester, WW Hancock, S Merani … - American Journal of Transplantation, 2007 - interscience.wiley.com Complex interactions between positive and negative cosignaling receptors
ultimately determine the fate of the immune response. The recently identified
coinhibitory receptor, B and T lymphocyte attenuator (BTLA), contributes to ... Cited by 16 - Related articles - BL Direct - All 3 versions
P Fiorina, A Secchi - Endocrinology and Metabolism Clinics of North …, 2007 - Elsevier Islet cell transplantation recently has emerged as one the most promising
therapeutic approaches to improving glycometabolic control in type 1 diabetic
patients, and, in many cases, to obtaining insulin independence. Islet cell ... Cited by 13 - Related articles - All 17 versions
- ►ualberta.ca [PDF] RG Bretzel, H Jahr, M Eckhard, I Martin, D … - Langenbeck's Archives of Surgery, 2007 - Springer Abstract Introduction Long-term studies strongly suggest that tight control of
blood glucose can prevent the development and retard the progression of chronic
complications of type 1 diabetes mellitus. In contrast to conventional ... Cited by 12 - Related articles - BL Direct - All 5 versions
S Marzorati, A Pileggi, C Ricordi - Expert Opin. Biol. Ther., 2007 - informahealthcare.com Significant progress has been made in the field of β-cell replacement therapies
by islet transplantation in patients with unstable Type 1 diabetes mellitus
(T1DM). Recent clinical trials have shown that islet transplantation can ... Cited by 11 - Related articles - BL Direct - All 6 versions
T Berney, A Secchi - Transplant International, 2009 - interscience.wiley.com The Edmonton protocol was undoubtedly a major step forward in the history of
islet transplantation. Its immunosuppression regimen was largely based on the
mTOR inhibitor rapamycin (sirolimus), which remains the most frequently ... Cited by 2 - Related articles - All 3 versions
D Mineo, J Sageshima, GW Burke, C Ricordi - Transplant International, 2009 - interscience.wiley.com For reducing the corticosteroid (CS)-related side-effects, especially
cardiovascular events, CS-sparing protocols have become increasingly common in
pancreas transplantation (PT). Lympho-depleting induction antibodies, such ... Cited by 1 - Related articles - All 3 versions
CB Leitão, P Cure, S Messinger, A Pileggi, O … - Transplantation, 2009 - journals.lww.com The study was supported by National Institutes of Health/National Cen- ter for
Research Resources (U42 RR016603, M01RR16587); Juvenile Diabetes Research
Foundation International (#4-2000-946, 4-2004- 361); National Institutes of ... Related articles - All 3 versions
MC Vantyghem, J Kerr-Conte, L Arnalsteen, G … - Diabetes Care, 2009 - Am Diabetes Assoc RESEARCH DESIGN AND METHODS A total of 14 consecutive patients with brittle type
1 diabetes were enrolled in this phase 2 study and received median 12,479 islet
equivalents per kilogram of body weight (interquartile range ... Cited by 1 - Related articles - All 3 versions
A Update - ihe.ca The Institute of Health Economics (IHE) is an independent, not-for-profit
organization that performs research in health economics and synthesizes evidence
in health technology assessment to assist health policy making and best ... Related articles - View as HTML
SF Grundfest-Broniatowski, G Tellioglu, KS … - ASAIO Journal, 2009 - journals.lww.com We have developed a replaceable bioartificial pancreas to treat diabetes
utilizing a unique cocontinous amphiphilic conetwork membrane created for
macroencapsulation and immunoisolation of porcine islet cells (PICs). The ... Related articles - All 3 versions
